Skip to content
2000
Volume 25, Issue 10
  • ISSN: 1871-5303
  • E-ISSN: 2212-3873
file format pdf download PDF
file format text download EPUB
side by side viewer icon HTML

Abstract

Background

Depression is a common mental illness that has become a major economic burden worldwide. Recently, increasing evidence has highlighted the inflammatory mechanism of depression. In order to understand the research status of this field, this study used the bibliometric analysis method to overview the research content and progress, as well as analyze the development trend and limitations.

Methods

In this study, articles and reviews were included in the specific search strategy. The matched papers were exported from the Web of Science database. CiteSpace 6.3 R1 and Bibliometrix (R package) were utilized to generate bibliometric and knowledge maps.

Results

A total of 25,063 articles were included in this study. The number of publications in this field has gradually increased, especially in recent years. These papers come from 156 countries, led by the United States and China mainland. The leading research institution is the University of Toronto (Canada). Brain Behavior and Immunity is the journal with the most publications and the most frequently co-cited journals. Among 91,100 authors, Maes M has the most publications and co-citations. According to the keywords burst and co-cited reference analysis, the hotspots in the field in recent years include kynurenine, c-reactive protein, neuroinflammation, and gut microbiota.

Conclusion

Although abundant academic achievements have been made on the inflammatory mechanism of depression, there is still a long way to go before these research results can be applied to clinical practice. Strengthening international academic exchanges and cooperation may promote breakthroughs in this field.

© 2025 The Author(s).
Published by Bentham Science Publishers. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/emiddt/10.2174/0118715303325541241024060229
2025-01-08
2025-08-13

  • From This Site

    /content/journals/emiddt/10.2174/0118715303325541241024060229
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
The full text of this item is not currently available.

References

  1. HuangY. LiY. PanH. HanL. Global, regional, and national burden of neurological disorders in 204 countries and territories worldwide.J. Glob. Health2023130416010.7189/jogh.13.0416038018250
     [Google Scholar]
  2. MalhiG.S. MannJ.J. Depression.Lancet2018392101612299231210.1016/S0140‑6736(18)31948‑230396512
     [Google Scholar]
  3. KumarM. NjugunaS. AminN. KananaS. TeleA. KaranjaM. OmarN. YatorO. WambuguC. BukusiD. WeaverM.R. Burden and risk factors of mental and substance use disorders among adolescents and young adults in Kenya: Results from the global burden of disease study 2019.EClinicalMedicine20246710232810.1016/j.eclinm.2023.10232838204491
     [Google Scholar]
  4. Factsheets: Depression2021Available from: www.who.int/news- room/fact-sheets/detail/depression
  5. SantomauroD.F. Mantilla HerreraA.M. ShadidJ. ZhengP. AshbaughC. PigottD.M. AbbafatiC. AdolphC. AmlagJ.O. AravkinA.Y. Bang-JensenB.L. BertolacciG.J. BloomS.S. CastellanoR. CastroE. ChakrabartiS. ChattopadhyayJ. CogenR.M. CollinsJ.K. DaiX. DangelW.J. DapperC. DeenA. EricksonM. EwaldS.B. FlaxmanA.D. FrostadJ.J. FullmanN. GilesJ.R. GirefA.Z. GuoG. HeJ. HelakM. HullandE.N. IdrisovB. LindstromA. LinebargerE. LotufoP.A. LozanoR. MagistroB. MaltaD.C. MånssonJ.C. MarinhoF. MokdadA.H. MonastaL. NaikP. NomuraS. O’HalloranJ.K. OstroffS.M. PasovicM. PenberthyL. ReinerR.C.Jr ReinkeG. RibeiroA.L.P. SholokhovA. SorensenR.J.D. VaravikovaE. VoA.T. WalcottR. WatsonS. WiysongeC.S. ZiglerB. HayS.I. VosT. MurrayC.J.L. WhitefordH.A. FerrariA.J. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic.Lancet2021398103121700171210.1016/S0140‑6736(21)02143‑734634250
     [Google Scholar]
  6. PirkisJ. JohnA. ShinS. DelPozo-BanosM. AryaV. Analuisa-AguilarP. ApplebyL. ArensmanE. BantjesJ. BaranA. BertoloteJ.M. BorgesG. BrečićP. CaineE. CastelpietraG. ChangS.S. ColchesterD. CromptonD. CurkovicM. DeisenhammerE.A. DuC. DwyerJ. ErlangsenA. FaustJ.S. FortuneS. GarrettA. GeorgeD. GerstnerR. GilissenR. GouldM. HawtonK. KanterJ. KapurN. KhanM. KirtleyO.J. KnipeD. KolvesK. LeskeS. MarahattaK. Mittendorfer-RutzE. NeznanovN. NiederkrotenthalerT. NielsenE. NordentoftM. OberlerchnerH. O’ConnorR.C. PearsonM. PhillipsM.R. PlattS. PlenerP.L. PsotaG. QinP. RadeloffD. RadosC. ReifA. Reif-LeonhardC. RozanovV. SchlangC. SchneiderB. SemenovaN. SinyorM. TownsendE. UedaM. VijayakumarL. WebbR.T. WeerasingheM. ZalsmanG. GunnellD. SpittalM.J. Suicide trends in the early months of the COVID-19 pandemic: An interrupted time-series analysis of preliminary data from 21 countries.Lancet Psychiatry20218757958810.1016/S2215‑0366(21)00091‑233862016
     [Google Scholar]
  7. MiguelT.L. BertiR. BlazhenetsG. DomogallaL.C. SteinackerN. OmraneM.A. MeyerP.T. CoenenV.A. EderA.C. DöbrössyM.D. Reserpine-induced rat model for depression: Behavioral, physiological and PET-based dopamine receptor availability validation.Prog. Neuropsychopharmacol. Biol. Psychiatry202413311101310.1016/j.pnpbp.2024.11101338636702
     [Google Scholar]
  8. XuY. LiR. HuC. HeY. ZhangX. JinL. Global, regional, and national incidence trends of depressive disorder, 1990–2019: An age-period-cohort analysis based on the global burden of disease 2019 study.Gen. Hosp. Psychiatry202488516010.1016/j.genhosppsych.2024.03.00338508076
     [Google Scholar]
  9. MurrayC.J.L. AravkinA.Y. ZhengP. AbbafatiC. AbbasK.M. Abbasi-KangevariM. Abd-AllahF. AbdelalimA. AbdollahiM. AbdollahpourI. AbegazK.H. AbolhassaniH. AboyansV. AbreuL.G. AbrigoM.R.M. AbualhasanA. Abu-RaddadL.J. AbushoukA.I. AdabiM. AdekanmbiV. AdeoyeA.M. AdetokunbohO.O. AdhamD. AdvaniS.M. AgarwalG. AghamirS.M.K. AgrawalA. AhmadT. AhmadiK. AhmadiM. AhmadiehH. AhmedM.B. AkaluT.Y. AkinyemiR.O. AkinyemijuT. AkombiB. AkunnaC.J. AlahdabF. Al-AlyZ. AlamK. AlamS. AlamT. AlaneziF.M. AlanziT.M. AlemuB. AlhabibK.F. AliM. AliS. AlicandroG. AliniaC. AlipourV. AlizadeH. AljunidS.M. AllaF. AllebeckP. Almasi-HashianiA. Al-MekhlafiH.M. AlonsoJ. AltirkawiK.A. Amini-RaraniM. AmiriF. AmugsiD.A. AncuceanuR. AnderliniD. AndersonJ.A. AndreiC.L. AndreiT. AngusC. AnjomshoaM. AnsariF. Ansari-MoghaddamA. AntonazzoI.C. AntonioC.A.T. AntonyC.M. AntriyandartiE. AnvariD. AnwerR. AppiahS.C.Y. ArablooJ. Arab-ZozaniM. ArianiF. ArmoonB. ÄrnlövJ. ArzaniA. Asadi-AliabadiM. Asadi-PooyaA.A. AshbaughC. AssmusM. AtafarZ. AtnafuD.D. AtoutM.M.W. AusloosF. AusloosM. AyalaQ.B.P. AyanoG. AyanoreM.A. AzariS. AzarianG. AzeneZ.N. BadawiA. BadiyeA.D. BahramiM.A. BakhshaeiM.H. BakhtiariA. BakkannavarS.M. BaldasseroniA. BallK. BallewS.H. BalziD. BanachM. BanerjeeS.K. BanteA.B. BarakiA.G. Barker-ColloS.L. BärnighausenT.W. BarreroL.H. BarthelemyC.M. BaruaL. BasuS. BauneB.T. BayatiM. BeckerJ.S. BediN. BeghiE. BéjotY. BellM.L. BennittF.B. BensenorI.M. BerheK. BermanA.E. BhagavathulaA.S. BhageerathyR. BhalaN. BhandariD. BhattacharyyaK. BhuttaZ.A. BijaniA. BikbovB. Bin SayeedM.S. BiondiA. BirihaneB.M. BisignanoC. BiswasR.K. BitewH. BohlouliS. BohluliM. Boon-DooleyA.S. BorgesG. BorzìA.M. BorzoueiS. BosettiC. BoufousS. BraithwaiteD. BreitbordeN.J.K. BreitnerS. BrennerH. BriantP.S. BrikoA.N. BrikoN.I. BrittonG.B. BryazkaD. BumgarnerB.R. BurkartK. BurnettR.T. BuruginaN.S. ButtZ.A. Caetano dos SantosF.L. CahillL.E. CámeraL.L.A.A. Campos-NonatoI.R. CárdenasR. CarrerasG. CarreroJ.J. CarvalhoF. Castaldelli-MaiaJ.M. Castañeda-OrjuelaC.A. CastelpietraG. CastroF. CauseyK. CederrothC.R. CercyK.M. CerinE. ChandanJ.S. ChangK-L. CharlsonF.J. ChattuV.K. ChaturvediS. CherbuinN. Chimed-OchirO. ChoD.Y. ChoiJ-Y.J. ChristensenH. ChuD-T. ChungM.T. ChungS-C. CicuttiniF.M. CiobanuL.G. CirilloM. ClassenT.K.D. CohenA.J. ComptonK. CooperO.R. CostaV.M. CousinE. CowdenR.G. CrossD.H. CruzJ.A. DahlawiS.M.A. DamascenoA.A.M. DamianiG. DandonaL. DandonaR. DangelW.J. DanielssonA-K. DarganP.I. DarweshA.M. DaryaniA. DasJ.K. Das GuptaR. das NevesJ. Dávila-CervantesC.A. DavitoiuD.V. De LeoD. DegenhardtL. DeLangM. DellavalleR.P. DemekeF.M. DemozG.T. DemsieD.G. Denova-GutiérrezE. DervenisN. DhunganaG.P. DianatinasabM. Dias da SilvaD. DiazD. DibajiF.Z.S. DjalaliniaS. DoH.T. DokovaK. DorostkarF. DoshmangirL. DriscollT.R. DuncanB.B. DuraesA.R. EaganA.W. EdvardssonD. El NahasN. El SayedI. El TantawiM. ElbaraziI. ElgendyI.Y. El-JaafaryS.I. ElyazarI.R.F. Emmons-BellS. ErskineH.E. EskandariehS. EsmaeilnejadS. EsteghamatiA. EstepK. EtemadiA. EtissoA.E. FanzoJ. FarahmandM. FareedM. FaridniaR. FarioliA. FaroA. FaruqueM. FarzadfarF. FattahiN. FazlzadehM. FeiginV.L. FeldmanR. FereshtehnejadS-M. FernandesE. FerraraG. FerrariA.J. FerreiraM.L. FilipI. FischerF. FisherJ.L. FlorL.S. FoigtN.A. FolayanM.O. FomenkovA.A. ForceL.M. ForoutanM. FranklinR.C. FreitasM. FuW. FukumotoT. FurtadoJ.M. GadM.M. GakidouE. GallusS. Garcia-BasteiroA.L. GardnerW.M. GeberemariyamB.S. GebreslassieA.A.A.A. GeremewA. GershbergH.A. GethingP.W. GhadimiM. GhadiriK. GhaffarifarF. GhafourifardM. GhamariF. GhashghaeeA. GhiasvandH. GhithN. GholamianA. GhoshR. GillP.S. GinindzaT.G.G. GiussaniG. GnedovskayaE.V. GoharinezhadS. GopalaniS.V. GoriniG. GoudarziH. GoulartA.C. GreavesF. GrivnaM. GrossoG. GubariM.I.M. GugnaniH.C. GuimarãesR.A. GuledR.A. GuoG. GuoY. GuptaR. GuptaT. HaddockB. Hafezi-NejadN. HafizA. Haj-MirzaianA. Haj-MirzaianA. HallB.J. HalvaeiI. HamadehR.R. HamidiS. HammerM.S. HankeyG.J. HaririanH. HaroJ.M. HasaballahA.I. HasanM.M. HasanpoorE. HashiA. HassanipourS. HassankhaniH. HavmoellerR.J. HayS.I. HayatK. HeidariG. Heidari-SoureshjaniR. HenriksonH.J. HerbertM.E. HerteliuC. HeydarpourF. HirdT.R. HoekH.W. HollaR. HoogarP. HosgoodH.D. HossainN. HosseiniM. HosseinzadehM. HostiucM. HostiucS. HousehM. HsairiM. HsiehV.C. HuG. HuK. HudaT.M. HumayunA. HuynhC.K. HwangB-F. IannucciV.C. IbitoyeS.E. IkedaN. IkutaK.S. IlesanmiO.S. IlicI.M. IlicM.D. InbarajL.R. IppolitoH. IqbalU. IrvaniS.S.N. IrvineC.M.S. IslamM.M. IslamS.M.S. IsoH. IversR.Q. IwuC.C.D. IwuC.J. IyamuI.O. JaafariJ. JacobsenK.H. JafariH. JafariniaM. JahaniM.A. JakovljevicM. JalilianF. JamesS.L. JanjaniH. JavaheriT. JavidniaJ. JeemonP. JenabiE. JhaR.P. JhaV. JiJ.S. JohanssonL. JohnO. John-AkinolaY.O. JohnsonC.O. JonasJ.B. JoukarF. JozwiakJ.J. JürissonM. KabirA. KabirZ. KalaniH. KalaniR. KalankeshL.R. KalhorR. KanchanT. KapoorN. Karami MatinB. KarchA. KarimM.A. KassaG.M. KatikireddiS.V. KayodeG.A. KazemiK.A. KeiyoroP.N. KellerC. KemmerL. KendrickP.J. KhalidN. KhammarniaM. KhanE.A. KhanM. KhatabK. KhaterM.M. KhatibM.N. KhayamzadehM. KhazaeiS. KielingC. KimY.J. KimokotiR.W. KisaA. KisaS. KivimäkiM. KnibbsL.D. KnudsenA.K.S. KocarnikJ.M. KochharS. KopecJ.A. KorshunovV.A. KoulP.A. KoyanagiA. KraemerM.U.G. KrishanK. KrohnK.J. KromhoutH. KuateD.B. KumarG.A. KumarV. KurmiO.P. KusumaD. La VecchiaC. LaceyB. LalD.K. LallooR. LallukkaT. LamiF.H. LandiresI. LangJ.J. LanganS.M. LarssonA.O. LasradoS. LauriolaP. LazarusJ.V. LeeP.H. LeeS.W.H. LeGrandK.E. LeighJ. LeonardiM. LescinskyH. LeungJ. LeviM. LiS. LimL-L. LinnS. LiuS. LiuS. LiuY. LoJ. LopezA.D. LopezJ.C.F. LopukhovP.D. LorkowskiS. LotufoP.A. LuA. LugoA. MaddisonE.R. MahashaP.W. MahdaviM.M. MahmoudiM. MajeedA. MalekiA. MalekiS. MalekzadehR. MaltaD.C. MamunA.A. MandaA.L. ManguerraH. Mansour-GhanaeiF. MansouriB. MansourniaM.A. MantillaH.A.M. MaravillaJ.C. MarksA. MartinR.V. MartiniS. Martins-MeloF.R. MasakaA. MasoumiS.Z. MathurM.R. MatsushitaK. MaulikP.K. McAlindenC. McGrathJ.J. McKeeM. MehndirattaM.M. MehriF. MehtaK.M. MemishZ.A. MendozaW. MenezesR.G. MengeshaE.W. MerekeA. MeretaS.T. MeretojaA. MeretojaT.J. MestrovicT. MiazgowskiB. MiazgowskiT. MichalekI.M. MillerT.R. MillsE.J. MiniG.K. MiriM. MiricaA. MirrakhimovE.M. MirzaeiH. MirzaeiM. MirzaeiR. Mirzaei-AlavijehM. MisganawA.T. MithraP. MoazenB. MohammadD.K. MohammadY. MohammadG.M.N. Mohammadian-HafshejaniA. MohammadifardN. MohammadpourhodkiR. MohammedA.S. MohammedH. MohammedJ.A. MohammedS. MokdadA.H. MolokhiaM. MonastaL. MooneyM.D. MoradiG. MoradiM. Moradi-LakehM. MoradzadehR. MoragaP. MorawskaL. Morgado-da-CostaJ. MorrisonS.D. MosapourA. MosserJ.F. MouodiS. MousaviS.M. MousaviK.A. MuellerU.O. MukhopadhyayS. MullanyE.C. MusaK.I. MuthupandianS. NabhanA.F. NaderiM. NagarajanA.J. NagelG. NaghaviM. NaghshtabriziB. NaimzadaM.D. NajafiF. NangiaV. NansseuJ.R. NaserbakhtM. NayakV.C. NegoiI. NgunjiriJ.W. NguyenC.T. NguyenH.L.T. NguyenM. NigatuY.T. NikbakhshR. NixonM.R. NnajiC.A. NomuraS. NorrvingB. NoubiapJ.J. NowakC. Nunez-SamudioV. OţoiuA. OanceaB. OdellC.M. OgboF.A. OhI-H. OkungaE.W. OladnabiM. OlagunjuA.T. OlusanyaB.O. OlusanyaJ.O. OmerM.O. OngK.L. OnwujekweO.E. OrpanaH.M. OrtizA. OsarenotorO. OseiF.B. OstroffS.M. OtstavnovN. OtstavnovS.S. ØverlandS. OwolabiM.O. P AM. PadubidriJ.R. PalladinoR. Panda-JonasS. PandeyA. ParryC.D.H. PasovicM. PasupulaD.K. PatelS.K. PathakM. PattenS.B. PattonG.C. PazokiT.H. PedenA.E. PenniniA. PepitoV.C.F. PeprahE.K. PereiraD.M. PesudovsK. PhamH.Q. PhillipsM.R. PiccinelliC. PilzT.M. PiradovM.A. PirsahebM. PlassD. PolinderS. PolkinghorneK.R. PondC.D. PostmaM.J. PourjafarH. PourmalekF. PoznańskaA. PradaS.I. PrakashV. PribadiD.R.A. PupilloE. Quazi SyedZ. RabieeM. RabieeN. RadfarA. RafieeA. RaggiA. RahmanM.A. Rajabpour-SanatiA. RajatiF. RakovacI. RamP. RamezanzadehK. RanabhatC.L. RaoP.C. RaoS.J. RashediV. RathiP. RawafD.L. RawafS. RawalL. RawassizadehR. RawatR. RazoC. RedfordS.B. ReinerR.C.Jr ReitsmaM.B. RemuzziG. RenjithV. RenzahoA.M.N. ResnikoffS. RezaeiN. RezaeiN. RezapourA. RhinehartP-A. RiahiS.M. RibeiroD.C. RibeiroD. RickardJ. RiveraJ.A. RobertsN.L.S. Rodríguez-RamírezS. RoeverL. RonfaniL. RoomR. RoshandelG. RothG.A. RothenbacherD. RubagottiE. RwegereraG.M. SabourS. SachdevP.S. SaddikB. SadeghiE. SadeghiM. SaeediR. SaeediM.S. SafariY. SafiS. SafiriS. SagarR. SahebkarA. SajadiS.M. SalamN. SalamatiP. SalemH. SalemM.R.R. SalimzadehH. SalmanO.M. SalomonJ.A. SamadZ. Samadi KafilH. SambalaE.Z. SamyA.M. SanabriaJ. Sánchez-PimientaT.G. SantomauroD.F. SantosI.S. SantosJ.V. Santric-MilicevicM.M. SaraswathyS.Y.I. Sarmiento-SuárezR. SarrafzadeganN. SartoriusB. SarveazadA. SathianB. SathishT. SattinD. SaxenaS. SchaefferL.E. SchiavolinS. SchlaichM.P. SchmidtM.I. SchutteA.E. SchwebelD.C. SchwendickeF. SenbetaA.M. SenthilkumaranS. SepanlouS.G. SerdarB. SerreM.L. ShadidJ. ShafaatO. ShahabiS. ShaheenA.A. ShaikhM.A. ShalashA.S. Shams-BeyranvandM. ShamsizadehM. SharafiK. SheikhA. SheikhtaheriA. ShibuyaK. ShieldK.D. ShigematsuM. ShinJ.I. ShinM-J. ShiriR. ShirkoohiR. ShuvalK. SiabaniS. SierpinskiR. SigfusdottirI.D. SigurvinsdottirR. SilvaJ.P. SimpsonK.E. SinghJ.A. SinghP. SkiadaresiE. SkouS.T. SkryabinV.Y. SmithE.U.R. SoheiliA. SoltaniS. SoofiM. SorensenR.J.D. SorianoJ.B. SorrieM.B. SoshnikovS. SoyiriI.N. SpencerC.N. SpotinA. SreeramareddyC.T. SrinivasanV. StanawayJ.D. SteinC. SteinD.J. SteinerC. StockfeltL. StokesM.A. StraifK. StubbsJ.L. SufiyanM.B. SuleriaH.A.R. SuliankatchiA.R. SuloG. SultanI. SzumowskiŁ. Tabarés-SeisdedosR. TabbK.M. TabuchiT. TaherkhaniA. TajdiniM. TakahashiK. TakalaJ.S. TamiruA.T. TaveiraN. Tehrani-BanihashemiA. TemsahM-H. TesemaG.A. TessemaZ.T. ThurstonG.D. TitovaM.V. TohidinikH.R. TonelliM. Topor-MadryR. TopouzisF. TorreA.E. TouvierM. Tovani-PaloneM.R.R. TranB.X. TravillianR. TsatsakisA. Tudor CarL. TyrovolasS. UddinR. UmeokonkwoC.D. UnnikrishnanB. UpadhyayE. VacanteM. ValdezP.R. van DonkelaarA. VasankariT.J. VasseghianY. VeisaniY. VenketasubramanianN. ViolanteF.S. VlassovV. VollsetS.E. VosT. VukovicR. WaheedY. WallinM.T. WangY. WangY-P. WatsonA. WeiJ. WeiM.Y.W. WeintraubR.G. WeissJ. WerdeckerA. WestJ.J. WestermanR. WhisnantJ.L. WhitefordH.A. WiensK.E. WolfeC.D.A. WozniakS.S. WuA-M. WuJ. WulfH.S. XuG. XuR. YadgirS. YahyazadehJ.S.H. YamagishiK. YaminfiroozM. YanoY. YayaS. Yazdi-FeyzabadiV. YeheyisT.Y. YilgwanC.S. YilmaM.T. YipP. YonemotoN. YounisM.Z. YounkerT.P. YousefiB. YousefiZ. YousefinezhadiT. YousufA.Y. YuC. YusefzadehH. ZahirianM.T. ZamaniM. ZamanianM. ZandianH. ZastrozhinM.S. ZhangY. ZhangZ-J. ZhaoJ.T. ZhaoX-J.G. ZhaoY. ZhouM. ZiapourA. ZimsenS.R.M. BrauerM. AfshinA. LimS.S. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: A systematic analysis for the global burden of disease study 2019.Lancet2020396102581223124910.1016/S0140‑6736(20)30752‑233069327
     [Google Scholar]
  10. YangF. LodderP. HuangN. LiuX. FuM. GuoJ. Thirty-year trends of depressive disorders in 204 countries and territories from 1990 to 2019: An age-period-cohort analysis.Psychiatry Res.202332811543310.1016/j.psychres.2023.11543337651839
     [Google Scholar]
  11. MaesM. MihaylovaI. KuberaM. RingelK. Activation of cell-mediated immunity in depression: Association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression.Prog. Neuropsychopharmacol. Biol. Psychiatry201236116917510.1016/j.pnpbp.2011.09.00621945535
     [Google Scholar]
  12. MillerA.H. MaleticV. RaisonC.L. Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression.Biol. Psychiatry200965973274110.1016/j.biopsych.2008.11.02919150053
     [Google Scholar]
  13. KokrasN. HodesG.E. BangasserD.A. DallaC. Sex differences in the hypothalamic–pituitary–adrenal axis: An obstacle to antidepressant drug development?Br. J. Pharmacol.2019176214090410610.1111/bph.1471031093959
     [Google Scholar]
  14. LynallM.E. McIntoshA.M. The heterogeneity of depression.Am. J. Psychiatry20231801070370410.1176/appi.ajp.2023057437777851
     [Google Scholar]
  15. LiuL. WangH. ChenX. ZhangY. ZhangH. XieP. Gut microbiota and its metabolites in depression: From pathogenesis to treatment.EBioMedicine20239010452710.1016/j.ebiom.2023.10452736963238
     [Google Scholar]
  16. GoldsmithD.R. BekhbatM. MehtaN.D. FelgerJ.C. Inflammation-related functional and structural dysconnectivity as a pathway to psychopathology.Biol. Psychiatry202393540541810.1016/j.biopsych.2022.11.00336725140
     [Google Scholar]
  17. JohnstonJ.N. GreenwaldM.S. HenterI.D. KrausC. MkrtchianA. ClarkN.G. ParkL.T. GoldP. ZarateC.A.Jr KadriuB. Inflammation, stress and depression: An exploration of ketamine’s therapeutic profile.Drug Discov. Today202328410351810.1016/j.drudis.2023.10351836758932
     [Google Scholar]
  18. KunugiH. Depression and lifestyle: Focusing on nutrition, exercise, and their possible relevance to molecular mechanisms.Psychiatry Clin. Neurosci.202377842043310.1111/pcn.1355136992617
     [Google Scholar]
  19. SmithR.S. The macrophage theory of depression.Med. Hypotheses199135429830610.1016/0306‑9877(91)90272‑Z1943879
     [Google Scholar]
  20. MaesM. SmithR. SimonS. The monocyte-T-lymphocyte hypothesis of major depression.Psychoneuroendocrinology199520211111610.1016/0306‑4530(94)00066‑J7899532
     [Google Scholar]
  21. WoelferM. KastiesV. KahlfussS. WalterM. The role of depressive subtypes within the neuroinflammation hypothesis of major depressive disorder.Neuroscience20194039311010.1016/j.neuroscience.2018.03.03429604382
     [Google Scholar]
  22. HotamisligilG.S. Inflammation, metaflammation and immunometabolic disorders.Nature2017542764017718510.1038/nature2136328179656
     [Google Scholar]
  23. KaranikasE. VlasidouD.I. Psychologically traumatic stress inducing redox – inflammation interplay; which comes first?Pharmacol. Biochem. Behav.202120917325410.1016/j.pbb.2021.17325434400213
     [Google Scholar]
  24. BauerM.E. TeixeiraA.L. Inflammation in psychiatric disorders: What comes first?Ann. N. Y. Acad. Sci.201914371576710.1111/nyas.1371229752710
     [Google Scholar]
  25. BraillonA. FriedE.I. CristeaI.A. CosgroveL. NaudetF. Treatments for major depression.Lancet202340110394211010.1016/S0140‑6736(23)00953‑437355287
     [Google Scholar]
  26. TelisN. LehmannB.V. FeldmanM.W. PritchardJ.K. A bibliometric history of the journal genetics.Genetics201620441337134210.1534/genetics.116.19696427927899
     [Google Scholar]
  27. JiangS. LiuY. ZhengH. ZhangL. ZhaoH. SangX. XuY. LuX. Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: A bibliometric analysis.Int. J. Surg.202310992774278310.1097/JS9.000000000000049237216225
     [Google Scholar]
  28. YeL. LiangR. LiuX. LiJ. YueJ. ZhangX. Frailty and sarcopenia: A bibliometric analysis of their association and potential targets for intervention.Ageing Res. Rev.20239210211110.1016/j.arr.2023.10211138031836
     [Google Scholar]
  29. ChenC. Searching for intellectual turning points: Progressive knowledge domain visualization.Proc. Natl. Acad. Sci. U S A.2004101 Suppl 1Suppl 15303531010.1073/pnas.0307513100
     [Google Scholar]
  30. ZouX. SunY. Bibliometrics analysis of the research status and trends of the association between depression and insulin from 2010 to 2020.Front. Psychiatry20211268347410.3389/fpsyt.2021.68347434366917
     [Google Scholar]
  31. MaesM. OmbeletW. VerkerkR. BosmansE. ScharpéS. Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: Relationships to delivery-induced immune activation and early post-partum anxiety and depression.Psychol. Med.200131584785810.1017/S003329170100400711459382
     [Google Scholar]
  32. MaesM. The immunoregulatory effects of antidepressants.Hum. Psychopharmacol.20011619510310.1002/hup.19112404604
     [Google Scholar]
  33. MusselmanD.L. LawsonD.H. GumnickJ.F. ManatungaA.K. PennaS. GoodkinR.S. GreinerK. NemeroffC.B. MillerA.H. Paroxetine for the prevention of depression induced by high-dose interferon alfa.N. Engl. J. Med.20013441396196610.1056/NEJM20010329344130311274622
     [Google Scholar]
  34. KudohA. KatagaiH. TakazawaT. Plasma inflammatory cytokine response to surgical trauma in chronic depressed patients.Cytokine200113210410810.1006/cyto.2000.080211145850
     [Google Scholar]
  35. GodboutJP MoreauM LestageJ Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system.Europsychopharmacology.200833102341235110.1038/sj.npp.1301649
     [Google Scholar]
  36. McNallyL. BhagwagarZ. HannestadJ. Inflammation, glutamate, and glia in depression: A literature review.CNS Spectr.200813650151010.1017/S109285290001673418567974
     [Google Scholar]
  37. Depression and Other Common Mental Disorders: Global Health EstimatesWorld Health OrganizationGeneva2017
     [Google Scholar]
  38. KirazS. DemirE. Global scientific outputs of schizophrenia publications from 1975 to 2020: A bibliometric analysis.Psychiatr. Q.20219241725174410.1007/s11126‑021‑09937‑434341886
     [Google Scholar]
  39. ChenP. BaiW. LiX.H. FengY. CheungT. SuZ. BalbuenaL. XiangY.T. Research on major depression in China: A perspective from bibliometric analysis.J. Affect. Disord.202231517418110.1016/j.jad.2022.07.04635907481
     [Google Scholar]
  40. McdonaldE.M. MannA.H. ThomasH.C. Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers.Lancet198733085691175117810.1016/S0140‑6736(87)91319‑52890808
     [Google Scholar]
  41. BeurelE. ToupsM. NemeroffC.B. The bidirectional relationship of depression and inflammation: Double trouble.Neuron2020107223425610.1016/j.neuron.2020.06.00232553197
     [Google Scholar]
  42. ZhangY. LiuL. PengY.L. LiuY.Z. WuT.Y. ShenX.L. ZhouJ.R. SunD.Y. HuangA.J. WangX. WangY.X. JiangC.L. Involvement of inflammasome activation in lipopolysaccharide-induced mice depressive-like behaviors.CNS Neurosci. Ther.201420211912410.1111/cns.1217024279434
     [Google Scholar]
  43. DantzerR. O’ConnorJ.C. FreundG.G. JohnsonR.W. KelleyK.W. From inflammation to sickness and depression: when the immune system subjugates the brain.Nat. Rev. Neurosci.200891465610.1038/nrn229718073775
     [Google Scholar]
  44. RaisonC.L. RutherfordR.E. WoolwineB.J. ShuoC. SchettlerP. DrakeD.F. HaroonE. MillerA.H. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: The role of baseline inflammatory biomarkers.JAMA Psychiatry2013701314110.1001/2013.jamapsychiatry.422945416
     [Google Scholar]
  45. JonesB.D.M. MahmoodU. HodsollJ. ChaudhryI.B. KhosoA.B. HusainM.O. OrtizA. HusainN. MulsantB.H. YoungA.H. HusainM.I. Associations between peripheral inflammation and clinical phenotypes of bipolar depression in a lower-middle income country.CNS Spectr.202328671071810.1017/S109285292300231637160707
     [Google Scholar]
  46. YoungJ.J. BrunoD. PomaraN. A review of the relationship between proinflammatory cytokines and major depressive disorder.J. Affect. Disord.2014169152010.1016/j.jad.2014.07.03225128861
     [Google Scholar]
  47. HowrenM.B. LamkinD.M. SulsJ. Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis.Psychosom. Med.200971217118610.1097/PSY.0b013e3181907c1b19188531
     [Google Scholar]
  48. BarberioB. ZamaniM. BlackC.J. SavarinoE.V. FordA.C. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: A systematic review and meta-analysis.Lancet Gastroenterol. Hepatol.20216535937010.1016/S2468‑1253(21)00014‑533721557
     [Google Scholar]
  49. MoustafaA.T. MoazzamiM. EngelL. BangertE. HassaneinM. MarzoukS. KravtsenyukM. FungW. EderL. SuJ. WitherJ.E. ToumaZ. Prevalence and metric of depression and anxiety in systemic lupus erythematosus: A systematic review and meta-analysis.Semin. Arthritis Rheum.2020501849410.1016/j.semarthrit.2019.06.01731303437
     [Google Scholar]
  50. ChanV.K.Y. LuoH. ChanS.S.M. LauC.S. YeungW.W.Y. PengK. TongX. LamM.P.S. WongI.C.K. LiX. Treatment-resistant depression and risk of autoimmune diseases: evidence from a population-based cohort and nested case-control study.Transl. Psychiatry20231317610.1038/s41398‑023‑02383‑936864045
     [Google Scholar]
  51. ShimoY. CathomasF. LinH. ChanK.L. PariseL.F. LiL. Ferrer-PérezC. MuharebS. CostiS. MurroughJ.W. RussoS.J. Social stress induces autoimmune responses against the brain.Proc. Natl. Acad. Sci. USA202312049e230577812010.1073/pnas.230577812038011565
     [Google Scholar]
  52. FotopoulosA. PetrikisP. SiokaC. Depression and coronary artery disease.Psychiatr. Danub.20213317333857047
     [Google Scholar]
  53. McFarlandD.C. DohertyM. AtkinsonT.M. O’HanlonR. BreitbartW. NelsonC.J. MillerA.H. Cancer-related inflammation and depressive symptoms: Systematic review and meta-analysis.Cancer2022128132504251910.1002/cncr.3419335417925
     [Google Scholar]
  54. GoldS.M. Köhler-ForsbergO. Moss-MorrisR. MehnertA. MirandaJ.J. BullingerM. SteptoeA. WhooleyM.A. OtteC. Comorbid depression in medical diseases.Nat. Rev. Dis. Primers2020616910.1038/s41572‑020‑0200‑232820163
     [Google Scholar]
  55. MiloF. ImondiC. D’AmoreC. AngelinoG. KnafelzD. BracciF. Dall’OglioL. De AngelisP. TabariniP. Short-term psychodynamic psychotherapy in addition to standard medical therapy increases clinical remission in adolescents and young adults with inflammatory bowel disease: A randomised controlled trial.J. Crohn’s Colitis202418225626310.1093/ecco‑jcc/jjad14537621051
     [Google Scholar]
  56. AkechiT. YamaguchiT. UchidaM. ImaiF. MominoK. KatsukiF. SakuraiN. MiyajiT. MashikoT. HorikoshiM. FurukawaT.A. YoshimuraA. OhnoS. UehiroN. HigakiK. HasegawaY. AkahaneK. UchitomiY. IwataH. Smartphone psychotherapy reduces fear of cancer recurrence among breast cancer survivors: A fully decentralized randomized controlled clinical trial (J-SUPPORT 1703 Study).J. Clin. Oncol.20234151069107810.1200/JCO.22.0069936322882
     [Google Scholar]
  57. KoizumiT. SugishitaY. Suzuki-TakahashiY. NaraK. MiyagawaT. NakajimaM. SugimotoK. FutamuraM. FuruiT. TakaiY. MatsumotoH. YamauchiH. OhnoS. KataokaA. KawaiK. FukumaE. NogiH. TsugawaK. SuzukiN. Oncofertility-related psycho-educational therapy for young adult patients with breast cancer and their partners: Randomized controlled trial.Cancer2023129162568258010.1002/cncr.3479637082910
     [Google Scholar]
  58. BensonS. EnglerH. WegnerA. RebernikL. SpreitzerI. SchedlowskiM. ElsenbruchS. What makes you feel sick after inflammation? predictors of acute and persisting physical sickness symptoms induced by experimental endotoxemia.Clin. Pharmacol. Ther.2017102114115110.1002/cpt.61828074475
     [Google Scholar]
  59. BalterL.J.T. LiX. SchwielerL. ErhardtS. AxelssonJ. OlssonM.J. LasselinJ. LekanderM. Lipopolysaccharide-induced changes in the kynurenine pathway and symptoms of sickness behavior in humans.Psychoneuroendocrinology202315310611010.1016/j.psyneuen.2023.10611037075653
     [Google Scholar]
  60. SchaeferM. EngelbrechtaM.A. GutO. FiebichB.L. BauerJ. SchmidtF. GrunzeH. LiebK. Interferon alpha (IFNα) and psychiatric syndromes.Prog. Neuropsychopharmacol. Biol. Psychiatry200226473174610.1016/S0278‑5846(01)00324‑412188106
     [Google Scholar]
  61. XieX. WuX. ZhaoD. LiuY. DuQ. LiY. XuY. LiY. QiuY. YangY. Fluvoxamine alleviates bleomycin-induced lung fibrosis via regulating the cGAS-STING pathway.Pharmacol. Res.202318710657710.1016/j.phrs.2022.10657736435270
     [Google Scholar]
  62. KappelmannN. LewisG. DantzerR. JonesP.B. KhandakerG.M. Antidepressant activity of anti-cytokine treatment: A systematic review and meta-analysis of clinical trials of chronic inflammatory conditions.Mol. Psychiatry201823233534310.1038/mp.2016.16727752078
     [Google Scholar]
  63. MinX. WangG. CuiY. MengP. HuX. LiuS. WangY. Association between inflammatory cytokines and symptoms of major depressive disorder in adults.Front. Immunol.202314111077510.3389/fimmu.2023.111077536860860
     [Google Scholar]
  64. YangY. GuK. MengC. LiJ. LuQ. ZhouX. YanD. LiD. PeiC. LuY. RanS. LiJ. Relationship between sleep and serum inflammatory factors in patients with major depressive disorder.Psychiatry Res.202332911552810.1016/j.psychres.2023.11552837837811
     [Google Scholar]
  65. PolettiS. ZanardiR. MandelliA. AggioV. FinardiA. LorenziC. BorsellinoG. CarminatiM. ManfrediE. TomasiE. SpadiniS. ColomboC. DrexhageH.A. FurlanR. BenedettiF. Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: Safety, efficacy, and immunological biomarkers.Brain Behav. Immun.2024118526810.1016/j.bbi.2024.02.01938367846
     [Google Scholar]
  66. EsalatmaneshS. KashaniL. KhooshidehM. MoghaddamH.S. AnsariS. AkhondzadehS. Efficacy and safety of celecoxib for treatment of mild to moderate postpartum depression: A randomized, double-blind, placebo-controlled trial.Arch. Gynecol. Obstet.202330941429143910.1007/s00404‑023‑07042‑437097311
     [Google Scholar]
  67. MerzaM.T.A. SalmanD.M. JaafarH.M. Pentoxifylline as a novel add-on therapy for major depressive disorder in adult patients: A randomized, double-blind, placebo-controlled trial.Pharmacopsychiatry202457420521410.1055/a‑2291‑720438710206
     [Google Scholar]
  68. BorbélyÉ. SimonM. FuchsE. WiborgO. CzéhB. HelyesZ. Novel drug developmental strategies for treatment-resistant depression.Br. J. Pharmacol.202217961146118610.1111/bph.1575334822719
     [Google Scholar]
  69. ChenY. ZhangY. WangJ. LiS. WangY. ZhangZ. ZhangJ. XinC. WangY. RongP. Anti-neuroinflammation effects of transcutaneous auricular vagus nerve stimulation against depression-like behaviors via hypothalamic α7nAchR / JAK2 / STAT3 / NF-κB pathway in rats exposed to chronic unpredictable mild stress.CNS Neurosci. Ther.20232992634264410.1111/cns.1420737032645
     [Google Scholar]
  70. Winiarska-MieczanA. KwiecieńM. Jachimowicz-RogowskaK. DonaldsonJ. TomaszewskaE. Baranowska-WójcikE. Anti-inflammatory, antioxidant, and neuroprotective effects of polyphenols—polyphenols as an element of diet therapy in depressive disorders.Int. J. Mol. Sci.2023243225810.3390/ijms2403225836768580
     [Google Scholar]
  71. ChengY. DesseS. MartinezA. WorthenR.J. JopeR.S. BeurelE. TNFα disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice.Brain Behav. Immun.20186955656710.1016/j.bbi.2018.02.00329452218
     [Google Scholar]
  72. ZhengP. ZengB. ZhouC. LiuM. FangZ. XuX. ZengL. ChenJ. FanS. DuX. ZhangX. YangD. YangY. MengH. LiW. MelgiriN.D. LicinioJ. WeiH. XieP. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism.Mol. Psychiatry201621678679610.1038/mp.2016.4427067014
     [Google Scholar]
  73. O’ConnorJ.C. LawsonM.A. AndréC. MoreauM. LestageJ. CastanonN. KelleyK.W. DantzerR. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.Mol. Psychiatry200914551152210.1038/sj.mp.400214818195714
     [Google Scholar]
  74. O’ConnorJ.C. LawsonM.A. AndréC. BrileyE.M. SzegediS.S. LestageJ. CastanonN. HerkenhamM. DantzerR. KelleyK.W. Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior.J. Immunol.200918253202321210.4049/jimmunol.080272219234218
     [Google Scholar]
  75. IwataM. OtaK.T. LiX.Y. SakaueF. LiN. DutheilS. BanasrM. DuricV. YamanashiT. KanekoK. RasmussenK. GlasebrookA. KoesterA. SongD. JonesK.A. ZornS. SmaginG. DumanR.S. Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2X7 receptor.Biol. Psychiatry2016801122210.1016/j.biopsych.2015.11.02626831917
     [Google Scholar]
  76. NiklassonF. AgrenH. Brain energy metabolism and blood-brain barrier permeability in depressive patients: Analyses of creatine, creatinine, urate, and albumin in CSF and blood.Biol. Psychiatry1984198118312066498242
     [Google Scholar]
  77. RogersG.B. KeatingD.J. YoungR.L. WongM-L. LicinioJ. WesselinghS. From gut dysbiosis to altered brain function and mental illness: Mechanisms and pathways.Mol. Psychiatry201621673874810.1038/mp.2016.5027090305
     [Google Scholar]
  78. LinP. LiD. ShiY. LiQ. GuoX. DongK. ChenQ. LouX. LiZ. LiP. JinW. ChenS. SunY. SunJ. ChengX. Dysbiosis of the gut microbiota and kynurenine (Kyn) pathway activity as potential biomarkers in patients with major depressive disorder.Nutrients2023157175210.3390/nu1507175237049591
     [Google Scholar]
  79. Alcocer-GómezE. de MiguelM. Casas-BarqueroN. Núñez-VascoJ. Sánchez-AlcazarJ.A. Fernández-RodríguezA. CorderoM.D. NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder.Brain Behav. Immun.20143611111710.1016/j.bbi.2013.10.01724513871
     [Google Scholar]
  80. MurphyM.M. Can menopause cause autonomic dysreflexia?Sci. Nurs.199183831891705
     [Google Scholar]
  81. BlackD.S. O’ReillyG.A. OlmsteadR. BreenE.C. IrwinM.R. Mindfulness meditation and improvement in sleep quality and daytime impairment among older adults with sleep disturbances: A randomized clinical trial.JAMA Intern. Med.2015175449450110.1001/jamainternmed.2014.808125686304
     [Google Scholar]
  82. RethorstC.D. ToupsM.S. GreerT.L. NakoneznyP.A. CarmodyT.J. GrannemannB.D. HuebingerR.M. BarberR.C. TrivediM.H. Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder.Mol. Psychiatry201318101119112410.1038/mp.2012.12522925832
     [Google Scholar]
  83. SampsonE. KavakbasiE. MillsN.T. HoriH. SchubertK.O. FourrierC. BauneB.T. Emotional blunting in depression in the PREDDICT clinical trial: Inflammation-stratified augmentation of vortioxetine with celecoxib.Int. J. Neuropsychopharmacol.2024273pyad06610.1093/ijnp/pyad06638441216
     [Google Scholar]
  84. HerbertT.B. CohenS. Depression and immunity: A meta-analytic review.Psychol. Bull.1993113347248610.1037/0033‑2909.113.3.4728316610
     [Google Scholar]
  85. WetsmanN. Inflammatory illness: Why the next wave of antidepressants may target the immune system.Nat. Med.20172391009101110.1038/nm0917‑100928886000
     [Google Scholar]
  86. ThombsB.D. BassE.B. FordD.E. StewartK.J. TsilidisK.K. PatelU. FauerbachJ.A. BushD.E. ZiegelsteinR.C. Prevalence of depression in survivors of acute myocardial infarction.J. Gen. Intern. Med.2006211303810.1111/j.1525‑1497.2005.00269.x16423120
     [Google Scholar]
  87. WhooleyM.A. Depression and cardiovascular disease: Healing the broken-hearted.JAMA2006295242874288110.1001/jama.295.24.287416804154
     [Google Scholar]
  88. LaneM.M. GamageE. DuS. AshtreeD.N. McGuinnessA.J. GauciS. BakerP. LawrenceM. RebholzC.M. SrourB. TouvierM. JackaF.N. O’NeilA. SegasbyT. MarxW. Ultra-processed food exposure and adverse health outcomes: Umbrella review of epidemiological meta-analyses.BMJ2024384e07731010.1136/bmj‑2023‑07731038418082
     [Google Scholar]
  89. MehdiS.M.A. CostaA.P. SvobC. PanL. DartoraW.J. TalatiA. GameroffM.J. WickramaratneP.J. WeissmanM.M. McIntireL.B.J. Depression and cognition are associated with lipid dysregulation in both a multigenerational study of depression and the national health and nutrition examination survey.Transl. Psychiatry202414114210.1038/s41398‑024‑02847‑638467624
     [Google Scholar]
  90. ShenR. ZouT. The association between cardiovascular health and depression: Results from the 2007–2020 NHANES.Psychiatry Res.202433111566310.1016/j.psychres.2023.11566338064908
     [Google Scholar]
  91. ShigaT. Depression and cardiovascular diseases.J. Cardiol.202381548549010.1016/j.jjcc.2022.11.01036410589
     [Google Scholar]
  92. KimH. LeeY.B. LeeJ. KangD. KimG. JinS.M. KimJ.H. HurK.Y. JeonH.J. Association between depression, antidepressant use, and the incidence of atherosclerotic cardiovascular diseases.J. Affect. Disord.202435221422110.1016/j.jad.2024.02.03438378089
     [Google Scholar]
  93. KrittanawongC. MaitraN.S. QadeerY.K. WangZ. FoggS. StorchE.A. CelanoC.M. HuffmanJ.C. JhaM. CharneyD.S. LavieC.J. Association of depression and cardiovascular disease.Am. J. Med.2023136988189510.1016/j.amjmed.2023.04.03637247751
     [Google Scholar]
  94. WillnerP. Animal models of depression: Validity and applications.Adv. Biochem. Psychopharmacol.19954919417653333
     [Google Scholar]
  95. HollisF. KabbajM. Social defeat as an animal model for depression.ILAR J.201455222123210.1093/ilar/ilu00225225302
     [Google Scholar]
  96. PlanchezB SurgetA BelzungC Animal models of major depression: Drawbacks and challenges.J. Neural. Transm. (Vienna).2019126111383140810.1007/s00702‑019‑02084‑y
     [Google Scholar]
  97. TseW.S. PochwatB. SzewczykB. MisztakP. BobulaB. TokarskiK. WorchR. Czarnota-BojarskaM. LiptonS.A. Zaręba-KoziołM. BijataM. WlodarczykJ. Restorative effect of NitroSynapsin on synaptic plasticity in an animal model of depression.Neuropharmacology202324110972910.1016/j.neuropharm.2023.10972937797736
     [Google Scholar]
  98. MingardiJ. NdojE. BonifacinoT. MisztakP. BertoliM. La ViaL. TorazzaC. RussoI. MilaneseM. BonannoG. PopoliM. BarbonA. MusazziL. Functional and molecular changes in the prefrontal cortex of the chronic mild stress rat model of depression and modulation by acute ketamine.Int. J. Mol. Sci.202324131081410.3390/ijms24131081437445990
     [Google Scholar]
  99. GonzalesE.L. JeonS.J. HanK.M. YangS.J. KimY. RemondeC.G. AhnT.J. HamB.J. ShinC.Y. Correlation between immune-related genes and depression-like features in an animal model and in humans.Brain Behav. Immun.2023113294310.1016/j.bbi.2023.06.01737379963
     [Google Scholar]
  100. FuQ. QiuR. ChenL. ChenY. QiW. ChengY. Music prevents stress-induced depression and anxiety-like behavior in mice.Transl. Psychiatry202313131710.1038/s41398‑023‑02606‑z37828015
     [Google Scholar]
  101. AfridiR. SukK. Neuroinflammatory basis of depression: Learning from experimental models.Front. Cell. Neurosci.20211569106710.3389/fncel.2021.69106734276311
     [Google Scholar]
  102. MatthewsK. ChristmasD. SwanJ. SorrellE. Animal models of depression: Navigating through the clinical fog.Neurosci. Biobehav. Rev.2005294-550351310.1016/j.neubiorev.2005.03.00515925695
     [Google Scholar]
  103. McArthurR. BorsiniF. Animal models of depression in drug discovery: A historical perspective.Pharmacol. Biochem. Behav.200684343645210.1016/j.pbb.2006.06.00516844210
     [Google Scholar]
  104. WangY.L. HanQ.Q. GongW.Q. PanD.H. WangL.Z. HuW. YangM. LiB. YuJ. LiuQ. Microglial activation mediates chronic mild stress-induced depressive- and anxiety-like behavior in adult rats.J. Neuroinflammation20181512110.1186/s12974‑018‑1054‑329343269
     [Google Scholar]
  105. GuilarteT.R. TSPO in diverse CNS pathologies and psychiatric disease: A critical review and a way forward.Pharmacol. Ther.2019194445810.1016/j.pharmthera.2018.09.00330189290
     [Google Scholar]
  106. De PickerL.J. MorrensM. BranchiI. HaarmanB.C.M. TeradaT. KangM.S. BocheD. TremblayM.E. LeroyC. BottlaenderM. OttoyJ. TSPO PET brain inflammation imaging: A transdiagnostic systematic review and meta-analysis of 156 case-control studies.Brain Behav. Immun.202311341543110.1016/j.bbi.2023.07.02337543251
     [Google Scholar]
  107. HolmesSE AbdallahC EsterlisI Imaging synaptic density in depression.Neuropsychopharmacology202348118619010.1038/s41386‑022‑01368‑4
     [Google Scholar]
  108. ZhouE. WangW. MaS. XieX. KangL. XuS. DengZ. GongQ. NieZ. YaoL. BuL. WangF. LiuZ. Prediction of anxious depression using multimodal neuroimaging and machine learning.Neuroimage202428512049910.1016/j.neuroimage.2023.12049938097055
     [Google Scholar]
  109. De PalmaG. BlennerhassettP. LuJ. DengY. ParkA.J. GreenW. DenouE. SilvaM.A. SantacruzA. SanzY. SuretteM.G. VerduE.F. CollinsS.M. BercikP. Microbiota and host determinants of behavioural phenotype in maternally separated mice.Nat. Commun.201561773510.1038/ncomms873526218677
     [Google Scholar]
  110. JeongS. ChokkallaA.K. DavisC.K. VemugantiR. Post-stroke depression: Epigenetic and epitranscriptomic modifications and their interplay with gut microbiota.Mol. Psychiatry202328104044405510.1038/s41380‑023‑02099‑837188778
     [Google Scholar]
  111. VaresiA. CampagnoliL.I.M. ChirumboloS. CandianoB. CarraraA. RicevutiG. EspositoC. PascaleA. The brain-gut-microbiota interplay in depression: A key to design innovative therapeutic approaches.Pharmacol. Res.202319210679910.1016/j.phrs.2023.10679937211239
     [Google Scholar]
  112. ZhouM. FanY. XuL. YuZ. WangS. XuH. ZhangJ. ZhangL. LiuW. WuL. YuJ. YaoH. WangJ. GaoR. Microbiome and tryptophan metabolomics analysis in adolescent depression: Roles of the gut microbiota in the regulation of tryptophan-derived neurotransmitters and behaviors in human and mice.Microbiome202311114510.1186/s40168‑023‑01589‑937386523
     [Google Scholar]
  113. Lyra e SilvaN.M. Barros-AragãoF.G.Q. De FeliceF.G. FerreiraS.T. Inflammation at the crossroads of COVID-19, cognitive deficits and depression.Neuropharmacology202220910902310.1016/j.neuropharm.2022.10902335257690
     [Google Scholar]
  114. MazzaM.G. PalladiniM. De LorenzoR. MagnaghiC. PolettiS. FurlanR. CiceriF. Rovere-QueriniP. BenedettiF. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up.Brain Behav. Immun.20219413814710.1016/j.bbi.2021.02.02133639239
     [Google Scholar]
  115. TaquetM. GeddesJ.R. HusainM. LucianoS. HarrisonP.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records.Lancet Psychiatry20218541642710.1016/S2215‑0366(21)00084‑533836148
     [Google Scholar]
  116. TanY. XieY. DongG. YinM. ShangZ. ZhouK. BaoD. ZhouJ. The effect of 14-day consumption of hydrogen-rich water alleviates fatigue but does not ameliorate dyspnea in long-COVID patients: A pilot, single-blind, and randomized, controlled trial.Nutrients20241610152910.3390/nu1610152938794767
     [Google Scholar]
  117. FarahaniR.H. AjamA. NaeiniA.R. Effect of fluvoxamine on preventing neuropsychiatric symptoms of post COVID syndrome in mild to moderate patients, a randomized placebo-controlled double-blind clinical trial.BMC Infect. Dis.202323119710.1186/s12879‑023‑08172‑537003990
     [Google Scholar]
  118. ZhangJ. SongL. JiaJ. TianW. LaiR. ZhangZ. LiJ. JuJ. XuH. Knowledge mapping of necroptosis From 2012 to 2021: A bibliometric analysis.Front. Immunol.20221391715510.3389/fimmu.2022.91715535769473
     [Google Scholar]
/content/journals/emiddt/10.2174/0118715303325541241024060229
Loading
Beyond the Surface: Tracing the Evolution of Inflammatory Mechanism in Depression through Bibliometric Analysis
Endocr Metab Immune Disord Drug Targets 25, 789 (2025); https://doi.org/10.2174/0118715303325541241024060229
/content/journals/emiddt/10.2174/0118715303325541241024060229
/content/journals/emiddt/10.2174/0118715303325541241024060229
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): bibliometric; citeSpace; Depression; inflammation; neuroimmunology; WoSCC

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test